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doi:10.1Objectives: Borderline left ventricle is the left ventricular morphology at the favorable end of the hypoplastic
left heart syndrome. In contrast to the severe end, it is suitable for biventricular repair. Wondering whether it is
possible to identify cases suitable for biventricular repair from a developmental viewpoint, we investigated the
myocardial histology of borderline and severely hypoplastic left ventricles.
Methods: Postmortem specimens of neonatal, unoperated human hearts with severe hypoplastic left heart syn-
drome and borderline left ventricle were compared with normal specimens and hearts from patients with trans-
position of the great arteries. After tissue sampling of the lateral walls of both ventricles, immunohistochemical
and immunofluorescence stainings against cardiac troponin I, N-cadherin, and connexin 43, important for proper
cardiac differentiation, were done.
Results:All severely hypoplastic left hearts (7/7) and most borderline left ventricle hearts (4/6) showed reduced
sarcomeric expressions of troponin I in left and right ventricles. N-cadherin and connexin 43 expressions were
reduced in intercalated disks. The remaining borderline left ventricle hearts (2/6) were histologically closer to
control hearts.
Conclusions: Four of 6 borderline left ventricle hearts showedmyocardial histopathology similar to the severely
hypoplastic left hearts. The remainder were similar to normal hearts. Our results and knowledge regarding the
role of epicardial-derived cells in myocardial differentiation lead us to postulate that an abnormal epicardial–
myocardial interaction could explain the observed histopathology. Defining the histopathologic severity with
preoperative myocardial biopsy samples of hearts with borderline left ventricle might provide a diagnostic
tool for preoperative decision making. (J Thorac Cardiovasc Surg 2012;144:1315-22)Hypoplastic left heart syndrome (HLHS) is a spectrum of
morphologic abnormalities of the left heart first described
by Noonan and Nadas.1 At the severe end, the left ventricle
is vestigial, in combination with aortic and mitral atresia. In
cases with mitral stenosis, the hypoplastic left ventricle can
show endocardial fibroelastosis with aortic atresia or severe
aortic stenosis.2 In contrast to the original definition, the
term HLHS has often been used to refer only to the severe
end of this spectrum. In this report, we use the term
HLHS as originally described. The term hypoplastic left
heart complex was introduced to refer to a subset at the
mild end of the HLHS spectrum, comprising small but func-
tional left ventricles without endocardial fibroelastosis and
no valvular atresia or severe stenosis.3 The term borderlinee Departments of Anatomy and Embryology,a Cardiothoracic Surgery,b
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The Journal of Thoracic and Carleft ventricle (BLV) has been used to indicate this favorable
end of the HLHS spectrum.4 In this study we use the term
hypoplastic left heart (HLH) to indicate the phenotype of
the left ventricle at the severe end of the HLHS spectrum
and BLV to indicate the phenotype of the left ventricle at
the favorable end.
Different therapeutic strategies have been described that
can be applied to neonates with HLHS.5 Cardiac transplan-
tation and univentricular surgical correction are the 2 possi-
bilities for the HLH phenotype. For the BLV phenotype,
both univentricular and biventricular repairs have been
described.5,6 Determination of whether a left ventricle is
adequate to maintain the systemic circulation is, however,
a major challenge in the decision making before the
operative correction. Despite reports in the literature of
the use of multiple diagnostic tools to aid in this decision
making, a conclusive diagnostic tool is still missing.6-8
A possible solution could be found in a different
developmental background of the myocardium of the
hearts with BLV and HLH phenotypes. In particular, very
little is known about the histology of left ventricular
myocardium across the HLHS spectrum.2,9-11
Recent studies on cardiogenesis have provided new in-
sight into the origin of the ventricular myocardium,diovascular Surgery c Volume 144, Number 6 1315
Abbreviations and Acronyms
BLV ¼ borderline left ventricle
Cx43 ¼ connexin 43
EPDC ¼ epicardium-derived cell
HLH ¼ hypoplastic left heart
HLHS ¼ hypoplastic left heart syndrome
ICD ¼ intercalated disk
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Denabling a better approach to understanding the develop-
mental background of the myocardium in HLHS. The myo-
cardium of the left and right ventricles is derived from
different progenitor cell populations, the first and the sec-
ond heart fields, respectively.12 The epicardium originates
from the second heart field and gives rise to epicardium-
derived cells (EPDCs). These EPDCs migrate into the
myocardial wall and, through epicardial–myocardial inter-
actions, exert an essential role in establishing myocardial
architecture.13,14
Studies in the past 2 decades showed that electromechan-
ical coupling between the cardiomyocytes is essential
for myocardial differentiation.14-16 In particular, the
intercalated disk (ICD) has a major role in the regulation of
the electromechanical transduction, incorporating adherence
junctions, desmosomes, and gap junctions. Adherence
junctions and desmosomes provide N-cadherin–mediated
intercellular adhesion and function as a platform for
cytoskeletal anchorage, whereas gap junctions composed of
connexin 43 (Cx43) are involved in cell–cell exchange.15,16
Recently, we investigated the role of EPDCs in myocardial
maturation in the mouse14 by studying the expression
patterns of troponin I, N-cadherin, and Cx43. Several
EPDC-depletionmodels during development showmyocar-
dial abnormalities, including ventricular noncompaction
and downregulation of myocardial N-cadherin and Cx43
expressions.14
In this study, we investigated normal human postmortem
hearts and compared these with specimens with HLH and
BLV phenotypes by using the aforementioned markers
involved in myocardial differentiation and ICD function.
Additionally, we evaluated the staining of these markers
in hearts from patients with transposition of the great ar-
teries to ensure that the observations made in HLH and
BLV were specific to these malformations. We hypothe-
sized that BLV and HLH might present with myocardial
histopathologic abnormalities in varying degrees of sever-
ity, which might be caused by abnormal myocardial devel-
opment and maturation regulated by EPDCs. Moreover, we
hypothesized that our findings might be helpful in provid-
ing an additional diagnostic tool for surgical decision
making.1316 The Journal of Thoracic and Cardiovascular SurMATERIALS AND METHODS
Selection
Twenty-two human heart specimens from patients who had not under-
gone operation, comprising 6 with normal anatomy, 7 with HLH pheno-
type, 6 with BLV phenotype, and 3 with transposition of the great
arteries, were studied. The hearts were selected according to the definition
criteria in the literature, as explained previously. In the HLH group, hearts
with mitral and aortic valve atresia as well as hearts showing mitral valve
stenosis and aortic valve atresia were included. Hearts with BLV phenotype
were defined as those in which the apex was formed by the right ventricle
and the left ventricular lumen was at least a third of the base–apex distance
of the right ventricle in the absence of right-sided abnormalities. The left
ventricle in BLV was small but functional, without macroscopic myocar-
dial abnormalities, valvular atresia, or severe stenosis. In the normal hearts,
the left ventriclewas larger than the right ventricle and the apex was formed
by the left ventricle without other morphologic abnormalities.
Morphologic measurements of cardiac structures were performed to re-
fine the selection. The length of the left ventricular lumen was measured
from the mid aortomitral continuity to the compact myocardium at the
apex, whereas the right ventricular lumen was measured from the base of
the pulmonary valve to the compact myocardium at the apex. A Z score
for the morphologic measurements was calculated (Table 1).
The hearts were obtained from the Leiden Collection of malformed
hearts (Department of Anatomy and Embryology, Leiden University
Medical Center, Leiden, The Netherlands). This collection includes hearts
preserved in ethanol and glycerin, dating from the early 1950s to the recent
era. This study was undertaken in accordance with the Dutch regulation for
the proper use of human tissue for medical research purposes.
Sampling
Transmural tissue blocks of approximately 53 5 mm were taken from
the free walls of both ventricles. The site of sampling was standardized
at the proximal third of ventricular base–apex length. The embedding
was standardized, and the samples were collected in 70% ethanol. The
samples were routinely processed for paraffin embedding and immunohis-
tochemical investigation. Transverse sections (5 mm) in the craniocaudal
direction were mounted on albumin and glycerin–coated glass slides in
order from 1 through 10.
Immunohistochemical Examination
After deparaffinization and rehydration of the slides, microwave antigen
retrieval was applied by heating 12 minutes at 98C in a citric acid buffer
(0.01 mol/L in distilled water, pH 6.0). Inhibition of endogenous peroxi-
dase was performed for 20 minutes with a solution of 0.3% hydrogen
peroxide in phosphate-buffered saline solution (PBS). The slides were
incubated overnight with the primary antibody anti–troponin I (1/200),
dissolved in PBS and polysorbate 20 with 1% bovine serum albumin. Be-
tween subsequent incubation steps, all slides were rinsed in PBS (2 times)
and PBS and polysorbate 20 (1 time). The slides were incubated 60minutes
with the secondary antibody goat anti–rabbit biotin (1/200) in goat serum
(1/66) in PBS and polysorbate 20. Subsequently, all slides were incubated
45 minutes with avidin–biotin complex reagent. For visualization, the
slides were incubated 10 minutes with 400 mg/mL 3-30diaminobenzidine
tetrahydrochloride dissolved in tris(hydroxymethyl)aminomethane mal-
eate buffer (pH, 7.6) to which 20 mL hydrogen peroxide was added. Coun-
terstaining was performed with 0.1% hematoxylin for 5 seconds, followed
by rinsing 10 minutes with tap water. All slides were dehydrated, mounted
with Entellan (Merck & Co, Inc, Whitehouse Station, NJ), and studied un-
der light microscopy.
Immunofluorescence
Double stainings for N-cadherin (1/500 mouse monoclonal antibody
GC-4; Sigma-Aldrich Co LLC, St Louis, Mo) and Cx43 (1/200 rabbitgery c December 2012
TABLE 1. Cardiac phenotype and postmortem (postfixation) measurements
Age (d) Phenotype RV Z* LV Z* TV Z* MV Z* PV Z* AV Z* Asc Ao Z* Ao arch
Hypoplastic left heart
3 MA, AA, PDA, PFO 32 0 10 5 13 3 0 5 9 2 0 6 2 5 Hypoplasia
11 MA, AA, PDA, PFO 30 0 10 5 10 0 0 5 7 0 0 6 0.5 7 3, coarctation
21 MA, AA, PDA, PFO 34 1 8 5 13 3 0 5 9 2 0 6 1.5 6 2.5, coarctation
2 MA, AA, PDA, PFO 36 1 18 3 15 5 0 5 8 1 0 6 3 4 Resected
1 MS, AA, PDA, PFO, EFE 28 1 10 5 8 2 2.5 3 6 1 0 6 1 6 Hypoplasia
0 MS, AA, PDA, PFO, EFE 36 1 10 5 13 3 2 4 9 2 0 6 0.5 7 Resected
4 MS, AA, PDA, PFO 36 1 12 4 13 3 3.5 3 7 0 0 6 1 6 3, coarctation
Borderline left ventricle
2 PDA, PFO, AV and sub-Ao stenosis 31 0 27 2 10 0 5 2 7 0 2.5 4 3.5 4 Hypoplasia
75 PDA, PFO, bicuspid AV 39 2 33 1 13 3 6 2 9 2 6 0 6 1 3, coarctation
17 PDA, sub-Ao stenosis, VSD 35 1 29 1 9 1 6 2 6 1 4 2 4 3 3, coarctation
11 PDA, small MV, VSD 36 1 35 0 13 3 6 2 9 2 6 0 7 0 Hypoplasia
8 PFO 37 1 36 0 10 0 8 1 7 0 6 0 6 1 2, coarctation
0y PDA, PFO — — — — — — — —
Normal hearts
49 PDA 35 1 43 1 11 1 9 0 8 1 6 0 7 0 5, normal
0 PDA, PFO 31 0 34 0 9 1 8 1 6 1 6 0 6 1 Resected
3 PDA, PFO 31 0 33 1 11 1 9 0 8 1 6 0 7 0 5.5, normal
68 PFO 36 1 45 1 11 1 10 1 7 0 7 1 7 0 5.5, normal
22 PFO 21 2 28 1 8 2 6 3 6 1 4.5 2 5.5 2 4.5, normal
1 No PFO, no PDA 29 0 36 0 10 0 10 1 6 1 6 0 7 0 5, normal
Transposition of the great arteries
9 PDA, PFO 33 0 42 1 9 1 8 1 6 1 6 0 6 1 5, normal
1 No PFO, no PDA 34 1 37 0 10 0 8 1 6 1 6 0 7 0 Resected
1 No PFO, no PDA 28 1 29 1 8 2 7 1 5 2 5 1 6 1 5, normal
All measurements are in millimeters. RV, Right ventricular lumen; LV, left ventricular lumen; TV, tricuspid valve; MV, mitral valve; PV, pulmonary valve; AV, aortic valve; Asc,
ascending; Ao, aorta; MA, mitral valve atresia; AA, aortic valve atresia; PDA, patent ductus arteriosus; PFO, patent foramen ovale; MS, mitral valve stenosis; EFE, endocardial
fibroelastosis; VSD, ventricular septal defect. *Z scores are calculated as follows: (raw scoremean for normal hearts)/SD for normal hearts. yThis heart was no longer available at
the time of measurement.
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Dpolyclonal antibody C6219; Sigma-Aldrich) were performed. Sections
were pretreated as described previously and incubated overnight with the
primary antibodies. Appropriate secondary antibodies for Cx43 (Alexa
Fluor 488–conjugated donkey antirabbit IgG (heavy and light chains)
highly crossabsorbed, A11029; Invitrogen-Molecular Probes, Breda, The
Netherlands) and for N-cadherin (Alexa Fluor 568–conjugated goat anti-
mouse IgG1, A21124; Invitrogen-Molecular Probes) were used for visual-
ization with a Leica microscope (DM 5500B; Leica Microsystems GmbH,
Wetzlar, Germany).RESULTS
Study of the histology revealed myocardial abnormalities
in all cases of HLH. Four of 6 hearts with BLV phenotype
showed abnormalities similar to the HLH cases. The re-
maining 2 BLV hearts showed histologic characteristics
similar to those of normal hearts. Surprisingly, the histo-
logic abnormalities observed in the left ventricles of the
hearts in the BLV and HLH groups were also detected in
the right ventricle.Histology of Normal Hearts and BLV, and HLH
Groups
Troponin I. In the normal hearts, the cardiomyocytes were
visualized by troponin I expression, which showed a clearThe Journal of Thoracic and Carbanded pattern corresponding to the sarcomeric organiza-
tion. There were no differences in expression between the
left and right ventricles (Figure 1, A and B). In 2 of 6 hearts
with BLV phenotype, most of the cardiomyocytes showed
troponin I sarcomeric expression, and the sarcomeres
were properly organized (Figure 1, C andD). In the remain-
ing 4 of 6 hearts with BLV phenotype, the banded pattern
shown by troponin I expression in the sarcomeres was al-
most completely absent (Figure 1, E and F). These hearts
with BLV phenotype were similar to the hearts with HLH
phenotype, in which troponin I expression in the sarcomeres
was also almost absent (Figure 1, G and H).
N-cadherin. N-cadherin expression in the normal hearts
was present in the properly organized ICDs (adherence
junctions) of all cardiomyocytes (Figure 2, A and B). Simi-
lar to the normal hearts, in 2 of 6 hearts with BLV pheno-
type, N-cadherin was expressed in the well-organized
ICDs of the cardiomyocytes (Figure 2, C and D). The re-
maining 4 of 6 (severely affected) hearts in the BLV group
demonstrated disorganized ICDs, and expression of N-cad-
herin in the ICDs was rare (Figure 2, E and F). Similar
abnormalities were observed in all hearts with HLH pheno-
type (Figure 2, G and H).diovascular Surgery c Volume 144, Number 6 1317
FIGURE 1. Immunohistochemical expression of troponin I visualizing the sarcomeres. In the normal hearts (A and B), the troponin I expression demon-
strates a clear banded pattern corresponding to the sarcomeric organization (arrowheads). In 2 of 6 hearts with borderline left ventricle (BLV) phenotype
(C and D), most of the cardiomyocytes show troponin I sarcomeric expression, and the sarcomeres are properly organized (arrowheads). In the remaining
4 of 6 hearts with borderline left ventricle phenotype (severely affected; E and F), the banded pattern is almost completely absent (compare with C and D).
These hearts are more similar to the hearts with hypoplastic left heart (HLH) phenotype (G and H), in which the troponin I expression in the sarcomeres is
seen in few cells (compare arrowheads with those in E and F). No major differences are seen in expression pattern between the left and right ventricles.
N, Nucleus; BLV, borderline left ventricle; HLH, hypoplastic left heart. Scale bars represent 10 mm.
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DConnexin 43. In the normal hearts, the expression of Cx43
was concentrated at the lateral borders and ICDs of the car-
diomyocytes (gap junctions; Figure 2, A and B). In 2 of 61318 The Journal of Thoracic and Cardiovascular Surhearts with BLV phenotype, Cx43 expression was seen in
the ICDs and lateral borders of the cardiomyocytes
(Figure 2, C and D), similar to the normal hearts. Thegery c December 2012
FIGURE 2. Immunofluorescent expression patterns of N-cadherin (red) and connexin 43 (Cx-43; green) visualizing, respectively, the adherence junction
and the gap junctions. In the normal hearts (A and B), N-cadherin expression is observed in the nicely organized intercalated disks (ICDs) of all cardio-
myocytes (arrows). In 2 of 6 hearts with the borderline left ventricle (BLV) phenotype (C and D), N-cadherin is expressed in the intercalated disks of all
cardiomyocytes, and the intercalated disks are well organized (arrows). The severely affected hearts with borderline left ventricle phenotype (E and F) dem-
onstrate more disorganized intercalated disks, and the expression of N-cadherin in the intercalated disks is diminished relative to controls (compare with
A–D). Similar observations are made in the hearts with hypoplastic left heart (HLH) phenotype (G and H). In the normal hearts (A and B), the expression of
connexin 43 is concentrated at the lateral borders (arrowheads) and intercalated disks (arrows), similar to the intercalated disks (arrows) and lateral borders
(arrowheads) of 2 of 6 hearts with borderline left ventricle phenotype (C and D). The severely affected hearts with borderline left ventricle phenotype (E and
F) show almost complete lack of connexin 43 expression in the intercalated disks (arrows) and lateral borders (arrowheads), with only a few cells expressing
connexin 43 in these locations. The expression pattern in the hearts with more severe borderline left ventricle phenotype is similar to that in hearts with
hypoplastic left heart phenotype (compare E and F with G andH): most of the cells show lack of connexin 43 in intercalated disks and lateral borders (arrows
and arrowheads, respectively). Nomajor differences in expression patterns of N-cadherin and connexin 43 are observed between the left and right ventricles.
In all images, 40,6-diamidino-2-phenylindole (DAPI) staining (blue) is shown as a reference. N, Nucleus; ICD, intercalated disk; BLV, borderline left
ventricle; HLH, hypoplastic left heart. Scale bars represent 10 mm.
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FIGURE 3. Immunohistochemical expression patterns (A and B) of troponin I and immunofluorescent expression patterns (B and C) of connexin (Cx-43;
green) and N-cadherin (red) in the cardiomyocytes of the hearts with transposition of the great arteries (TGA). Troponin I expression in both left (A) and right
(B) ventricles shows a clear banded pattern corresponding to the sarcomeric organization (black arrowheads). In both left (C) and right (D) ventricles,
N-cadherin is expressed in the intercalated disks (ICD; arrows), whereas connexin 43 is seen at the lateral borders (white arrowheads) and intercalated disks
(arrows) of the cardiomyocytes, resembling the expression pattern in the normal hearts. In C and D, 40,6-diamidino-2-phenylindole (DAPI) staining (blue) is
shown as a reference. N, Nucleus; TGA, transposition of the great arteries; ICD, intercalated disk. Scale bars indicate 10 mm.
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Dremaining 4 of 6 (severely affected) hearts in the BLV group
showed almost complete lack of Cx43 expression in the
ICDs and lateral borders of the cardiomyocytes (Figure 2,
E and F) and were thus similar to the hearts with HLH phe-
notype (Figure 2, G and H).
Histology of Hearts With Transposition of the Great
Arteries
Similar to the normal hearts, the cardiomyocytes in the
hearts with transposition of the great arteries were visual-
ized by troponin I expression as showing a clearly organized
sarcomeric banded pattern in both ventricles (Figure 3, A
and B). In addition, in the cardiomyocytes of the hearts
with transposition of the great arteries, both the N-cadherin
and the Cx43 expression patterns were similar to those ob-
served in the normal hearts. N-cadherin was expressed in
the ICDs (Figure 3, C and D), whereas Cx43 was seen at
the lateral borders and ICDs of the cardiomyocytes
(Figure 3, C and D).
DISCUSSION
Several studies have focused on various hemody-
namic6,7,11 and genetic8 mechanisms to elucidate the origin1320 The Journal of Thoracic and Cardiovascular Surof the HLHS. Earlier studies reported on the histopathology
of the coronary arteries,9,10 aortic arch,2 and mitral valve17
in hearts with the HLH phenotype. Data on myocardial
organization and possible pathology, however, have been
lacking. In this study, we observed myocardial pathology
in the left and right ventricles of hearts with both HLH
and BLV phenotypes. The latter observation is of interest,
because it indicates that the origin of the myocardium, be-
ing for the left ventricle the first heart field and for the right
ventricle the second heart field,12 cannot provide a conclu-
sive answer for understanding the hypoplasia of the left ven-
tricle and the histopathology in both ventricles.
We previously attempted to link the observed myocardial
histopathology with abnormal myocardial differentiation
and found several arguments for a role of the epicardium
and EPDCs.13 The EPDCs have an important role in myo-
cardial and valve differentiation, as well as in coronary
artery maturation.18 Disruption of the genes involved in
the second heart field at the venous pole leads to altered epi-
cardial and EPDC formation and to EPDC-related cardiac
malformations, including altered atrioventricular cushion
development, myocardial abnormalities, and anomalous
coronary vasculature formation.18 The latter observationgery c December 2012
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reported in a subset of cases with HLHS and endocardial
fibroelastosis.2,9,10
The histopathology of the myocardium of both ventricles
has been found to be related to the sarcomeric organization
and the ICDs. During the postnatal differentiation of the
ventricular myocardium, the ICD has a primary role in
the electromechanical signal transduction between the car-
diomyocytes, with the expression of Cx43 and N-cadherin
becoming more organized and concentrated in the ICD.16
Dysregulation of these proteins in the ICD leads to several
forms of myocardial pathology. In the left ventricle of hu-
man hearts with congestive heart failure, reductions in
Cx43 and N-cadherin expressions have been reported,19
a finding recently confirmed by in vitro and in vivo experi-
ments in rat hearts.15 Abnormalities in expression patterns
of Cx43 and N-cadherin in ICDs were observed in human
hearts with hypertrophic cardiomyopathy and ventricular
arrhythmias leading to sudden cardiac death.20 The ob-
served pathology reported as disorganized ICD and reduced
expression of Cx43 and N-cadherin in the ICD is similar
to our findings in hearts with HLH and severe BLV
phenotypes.
Recently, the roles of Cx43, N-cadherin, and troponin I in
maturation, alignment, and proliferation of the myocardium
have been reported.14 It was shown, in both in vivo and
in vitro experiments, that the EPDCs can stimulate the mat-
uration, alignment, and proliferation of the cardiomyocytes
by affecting the electromechanical transduction and the sig-
naling pathways related to the extracellular matrix.14 In the
in vitro experiments, the depletion of EPDCs resulted in
downregulation of Cx43 and N-cadherin expressions. In
addition, these cardiomyocytes showed also dysregulation
of the cellular array.
On the basis of the observations regarding the role of
EPDCs in myocardial development and the supporting re-
sults of the studies mentioned in the literature, we postulate
that an abnormal epicardial–myocardial interaction through
altered electromechanical signal transduction might pro-
vide an explanation for the observed myocardial pathology
in hearts with HLH and BLV phenotypes. The presence of
Cx43 and N-cadherin can be essential to support myocar-
dial function in a nonchallenged state. It has been reported
that Cx43 expression can be downregulated by 80% before
functional arrhythmogenic consequences are seen.21 The
observed pathology in some of the BLV group hearts could
be possibly linked, however, to being less favorable for
biventricular repair.
Histopathology as a Diagnostic Tool for Preoperative
Decision Making
With regard to the treatment of the BLV phenotype, both
univentricular and biventricular repairs have been de-
scribed.4 The operative decision is complicated, however,The Journal of Thoracic and Carby the lack of a proper definition of BLV. Several semiquan-
titative methods and criteria have been developed in the last
2 decades to determine whether the left ventricle in BLV is
adequate to maintain the systemic circulation after biven-
tricular repair; however, none appear to be conclusive. Be-
cause an inadequate decision may result in severe
complications and even in death, a conclusive diagnostic
tool for decision making is desirable.22-24
In the ‘‘gray zone’’ of the pathologic spectrum, it is ex-
tremely important that the surgical decision between
a biventricular and a univentricular operation is taken prop-
erly. If the decision to undertake a biventricular repair turns
out to be wrong, the repercussions will be permanent, in-
cluding irreversible pulmonary hypertension. On the other
hand, incorrectly choosing a univentricular palliation does
not necessarily imply that (if the left ventricle functions
better than thought before) biventricular repair is out of
the question. In addition, a recent study of Hoashi and
colleagues25 has demonstrated acceptable outcomes in pa-
tients who were initially treated with the intent to perform
single-ventricle palliation but had conversion to ‘‘1½- or
2-ventricle’’ physiology.
Currently, in part because of the recent implementation
of hybrid Norwood techniques,26,27 the decision for
univentricular versus biventricular management can be
postponed for several months. After the hybrid Norwood
procedure, it may be possible to perform myocardial
biopsies, which may prove to be a helpful tool in future
decision making.
In this study, we demonstrated in 2 of 6 hearts with mac-
roscopic BLV phenotype a histologic similarity to normal
hearts, while the other 4 of 6 showed a histologic similarity
to hearts with the HLH phenotype. We have also shown that
the observed downregulation of Cx43 and N-cadherin as
well as the lack of cardiac troponin I, demonstrating sarco-
meric disorganization, can be linked to myocardial pathol-
ogy seen in cardiac failure and cardiomyopathy. This
implies that less than optimal function is to be expected in
time in heats with the HLH phenotype and the severe type
of BLV. Defining the myocardial phenotype of the latter
category by preoperative histologic study of myocardial
biopsy specimens might provide a valuable diagnostic
tool for preoperative decision making in the choice of uni-
ventricular or biventricular repair.
Limitations and Perspectives
Although the results are very promising, the number of
studied hearts is too limited to draw statistically significant
conclusions. The data presented in this study are based on
the retrospective study of postmortem unoperated hearts.
A prospective, multicenter study will provide more reliable
results not only by comparing the myocardium of the unop-
erated BLVand HLH phenotypes but also by comparing the
myocardium of the monoventricular versus biventriculardiovascular Surgery c Volume 144, Number 6 1321
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Drepair of the BLV phenotype. Such a study will provide
clinical data that can conclusively support or rule out the hy-
pothesis of this study.
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